Skip to main content

Peer Review reports

From: Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss

Original Submission
3 Feb 2014 Submitted Original manuscript
4 Feb 2014 Author responded Author comments - Nicola Zetola
Resubmission - Version 2
4 Feb 2014 Submitted Manuscript version 2
9 Mar 2014 Author responded Author comments - Nicola Zetola
6 Mar 2014 Reviewed Reviewer Report - Young Ae Kang
Resubmission - Version 3
9 Mar 2014 Submitted Manuscript version 3
20 Jun 2014 Author responded Author comments - Nicola Zetola
2 Apr 2014 Reviewed Reviewer Report - Doosoo Jeon
Resubmission - Version 4
20 Jun 2014 Submitted Manuscript version 4
20 Jun 2014 Author responded Author comments - Nicola Zetola
Resubmission - Version 5
20 Jun 2014 Submitted Manuscript version 5
Publishing
30 Sep 2014 Editorially accepted
9 Oct 2014 Article published 10.1186/1471-2334-14-542

You can find further information about peer review here.

Back to article page